Epidemiology, Approaches to the Diagnosis and Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia

Status: Recruiting
Location: See location...
Study Type: Observational [Patient Registry]
SUMMARY

In connection with the transition to the 8th version of the classification of lung cancer according to the TNM system, there are currently no precise epidemiological data on stage III NSCLC, clinical characteristics of patients in this group, approaches to therapy and treatment results in the Russian Federation. The published statistics only provide information on the overall incidence of stage III lung, trachea and bronchial cancer, which is about 40%. This observational study will make it possible to characterize the Russian population of stage III non-small cell lung cancer patients, approaches to choosing a treatment option for stage III NSCLC and the outcomes of this treatment in real clinical practice.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: No
View:

• stage III non-small cell lung cancer

Locations
Other Locations
Russian Federation
National Medical Research Center of Oncology. N. N. Blokhin
Recruiting
Moscow
Contact Information
Primary
Konstantin Laktionov, Professor
lkoskos@mail.ru
+7-903-170-97-95
Backup
Valeriy Breder, Leading Researcher
vbreder@yandex.ru
+7-903-199-07-55
Time Frame
Start Date: January 10, 2020
Estimated Completion Date: March 31, 2023
Participants
Target number of participants: 1

This content was sourced from clinicaltrials.gov